Elevated platelet distribution width predicts poor prognosis in hepatocellular carcinoma

被引:27
|
作者
Zuo, Xiaomin [1 ]
Kong, Weihao [2 ]
Feng, Linfei [3 ]
Zhang, Huabing [4 ]
Meng, Xiangling [1 ]
Chen, Wei [1 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Gen Surg, 218 Jixi Ave, Hefei 230032, Anhui, Peoples R China
[2] Anhui Med Univ, Affiliated Hosp 1, Dept Emergency Med, Dept Emergency Surg, Hefei, Anhui, Peoples R China
[3] Anhui Med Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Hefei, Anhui, Peoples R China
[4] Anhui Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Hefei, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
Platelet distribution width; hepatocellular carcinoma; prognosis; CANCER; COUNT; METASTASIS; VOLUME;
D O I
10.3233/CBM-182076
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Previous studies have demonstrated that platelets play an important role in growth, invasion, and angiogenesis of a variety of tumors. Nevertheless, the prognostic role of platelet indices in hepatocellular carcinoma (HCC) has not been explored. The aim of this study was to explore the association between platelet indices and prognosis in HCC. METHOD: A total of 260 patients with HCC between January 2009 and December 2015 were retrospectively analyzed. The optimal platelet distribution width (PDW) cutoff value is identified by the receiver operating characteristic curve (ROC) curve. The relationship between PDW and clinicopathological features was assessed. The prognostic effects of PDW were assessed by using the Kaplan-Meier method and Cox regression model. RESULT: Elevated PDW level was significantly associated with portal hypertension, vascular invasion, and Child-Pugh grade. In addition, survival curve indicates that patients with high PDW levels have a worse prognosis than patients with low PDW levels (P < 0.001). Multivariate Cox regression analysis identified PDW as an independent factor of prognosis in HCC patients (hazard ratio: 4.460, 95% confidence interval: 2.308-8.619, P < 0.001). CONCLUSION: Elevated PDW may be a novel marker for predicting the prognosis of HCC, but further research is needed to validate our conclusions.
引用
收藏
页码:307 / 313
页数:7
相关论文
共 50 条
  • [41] Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
    He, Lu
    Zhou, Xinke
    Qu, Chen
    Tang, Yunqiang
    Zhang, Qiong
    Hong, Jian
    MEDICAL ONCOLOGY, 2013, 30 (04)
  • [42] High expression of the TEFM gene predicts poor prognosis in hepatocellular carcinoma
    Fei, Zai-Yi
    Wang, Wei-Si
    Li, Su-Fen
    Zi, Jia-Ji
    Yang, Li
    Liu, Ting
    Ao, Song
    Liu, Qian-Qian
    Cui, Qing-Hua
    Yu, Min
    Xiong, Wei
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (06) : 1291 - 1304
  • [43] High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
    Xu, Wenxiong
    Huang, Yanlin
    Mei, Yongyu
    Zhang, Yeqiong
    Luo, Qiumin
    Zhu, Shu
    Peng, Liang
    Gao, Zhiliang
    Liu, Ying
    Li, Jianguo
    CURRENT ONCOLOGY, 2022, 29 (11) : 8650 - 8667
  • [44] CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma
    YueGuo Li
    Hai Peng Yu
    Peng Zhang
    Hepatology International, 2016, 10 : 488 - 492
  • [45] Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
    Jiang, Jie
    Liu, Bin
    Liu, Ruilin
    Yang, Wenzhuo
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2517 - 2537
  • [46] Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
    Sun, Yifan
    Zhu, Shengbo
    Wu, Zhitong
    Huang, Yiyong
    Liu, Chunming
    Tang, Shifu
    Wei, Lili
    ONCOTARGET, 2017, 8 (14) : 23427 - 23435
  • [47] Elevated platelet distribution width and diabetes may serve as preoperative predictors of microvascular invasion in primary hepatocellular carcinoma
    Wang, Ling
    Jun, Liu
    Jia, Jian'an
    Rao, Chunmei
    Jiang, Yuhuan
    Peng, Liu
    Li, Huiming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2025, 151 (03)
  • [48] Elevated LncRNA TRERNA1 correlated with activation of HIF-1α predicts poor prognosis in hepatocellular carcinoma
    Qian, Yanyan
    Li, Yiping
    Ge, Yanping
    Song, Wei
    Fan, Hong
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 227
  • [49] High expression of ERCC5 predicts a poor prognosis in hepatocellular carcinoma
    Zheng, Xueyong
    Chen, Ke
    Liu, Xiaolong
    Jiang, Guangyi
    Liu, Hui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (07): : 3664 - 3670
  • [50] Loss of CD155 expression predicts poor prognosis in hepatocellular carcinoma
    Qu, Ping
    Huang, Xiaojun
    Zhou, Xingchun
    Lu, Zhuomin
    Liu, Fang'e
    Shi, Zhiyong
    Lu, Lin
    Wu, Yanqiu
    Chen, Yibing
    HISTOPATHOLOGY, 2015, 66 (05) : 706 - 714